Survival of pancreatic cancer cells lacking KRAS function

Survival of pancreatic cancer cells lacking KRAS function

Activating mutations in the proto-oncogene KRAS are a hallmark of pancreatic ductal adenocarcinoma (PDAC), an aggressive malignancy with few effective therapeutic options. Despite efforts to develop KRAS-targeted drugs, the absolute dependence of PDAC cells on KRAS remains incompletely understood. H...

Full description

Bibliographic Details
Main Authors: Noll, Elisa M., Sprick, Martin R., Trumpp, Andreas, Muzumdar, Mandar, Chen, Pan-Yu, Dorans, Kimberly, Chung, Katherine Minjee, Bhutkar, Arjun, Hong, Erin, Jacks, Tyler E.
Other Authors: Massachusetts Institute of Technology. Department of Biology
Format: Article
Published: Nature Publishing Group 2017
Online Access:http://hdl.handle.net/1721.1/112693
https://orcid.org/0000-0002-4450-7570
https://orcid.org/0000-0001-9119-8718
https://orcid.org/0000-0001-5785-8911

Internet

http://hdl.handle.net/1721.1/112693
https://orcid.org/0000-0002-4450-7570
https://orcid.org/0000-0001-9119-8718
https://orcid.org/0000-0001-5785-8911

Similar Items